Sun Pharmaceutical Industries Share Price Today - Live Blog for December 12, 2025

Sun Pharmaceutical Industries Ltd shares saw a -0.03% decrease, reaching a current market price of ₹1,794.50. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 41.3500, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.12% surge in its share price and is presently trading at ₹1,794.75, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.02%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,792.60, and market participants are assessing the implications. The stock has a PE ratio of 41.3500, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd share price has declined by -0.05%, and it's currently trading at ₹1,792.95. The stock maintains a PE of 41.3500, while the industry PE is 32.9342, prompting discussions about its valuation.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.14% decline, and it currently trades at ₹1,799.15 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd observed a -0.14% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,799.15. The stock has a PE ratio of 41.3500, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.14% decline and is currently trading at ₹1,799.15 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a -0.14% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,799.15. Investors should examine the factors driving this decline. The stock's PE ratio is 41.3500, whereas the industry PE ratio stands at 32.9342.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.14% decline, and it currently trades at ₹1,799.15 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.06% increase. Presently, it is actively trading at ₹1,801.60.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.22%, signalling a challenging period. Currently trading at ₹1,800.50, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.11%, reaching the current market price of ₹1,804.45. This development underscores the stock's growing popularity.

With a -0.09% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,802.60. The stock is currently trading at a PE of 41.3500, while the industry PE is 32.9342, prompting investors to assess its value proposition.

With a -0.15% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,802.30. This development raises questions about the factors behind the decline. The stock's PE ratio is 41.3500, while the industry PE is 32.9342.

With a -0.12% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,804.30. Investors should examine the factors driving this decline. The stock's PE ratio is 41.3500, whereas the industry PE ratio stands at 32.9342.

With a remarkable 0.08% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,806.40. Notably, this stock has a Price-to-Earnings (PE) ratio of 41.3500, while the industry's PE ratio is 32.9342.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.05% recently. As of now, this stock is actively trading at a current market price of ₹1,804.90 per share, attracting attention from investors.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.14% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,804.05 per share. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.04% uptick, and they are currently valued at ₹1,801.55, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.04%, reaching the current market price of ₹1,800.80. This ascent signifies increased investor sentiment. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.17% gain, with the share price now at ₹1,800.00. Notably, the stock's PE ratio stands at 41.3500, and its Return on Equity (ROE) is 14.8407%.

With a -0.03% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,796.70. The stock is currently trading at a PE of 41.3500, while the industry PE is 32.9342, prompting investors to assess its value proposition.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.04%, signalling a challenging period. Currently trading at ₹1,797.20, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.11% slump and is currently trading at ₹1,798.00. While the stock maintains a PE ratio of 41.3500, the industry PE is 32.9342, raising questions about valuation.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.11%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,798.00, and market participants are assessing the implications. The stock has a PE ratio of 41.3500, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd shares experienced a -0.17% reduction, with the current market price at ₹1,799.45. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.24%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,802.60, but investors are assessing whether this is a temporary dip or a long-term trend.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.17% in its share price, and it currently trades at ₹1,804.95 per share. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.22% boost, with the current market value at ₹1,808.05 per share. This surge has not gone unnoticed by investors.

The share price of Sun Pharmaceutical Industries Ltd experienced a -1.04% slump and is currently trading at ₹1,804.00. While the stock maintains a PE ratio of 41.3500, the industry PE is 32.9342, raising questions about valuation.